Drug Trial Radar · NCT03683186
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
1,000
Planned (sponsor's estimate)
Start
Sep 23, 2019
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- United TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Sep 25, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.
Conditions
- PAH
- Pulmonary Hypertension
- Pulmonary Arterial Hypertension
- Hypertension
- Connective Tissue Diseases
- Familial Primary Pulmonary Hypertension
- Vascular Diseases
- Cardiovascular Diseases
- Hypertension, Pulmonary
- Lung Diseases
- Respiratory Tract Disease
Interventions
RalinepagDrug
Active
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of subjects with treatment-emergent adverse events [Safety and Tolerability]Time frame: Up to 6 years
Locations
190 sites in 33 countries. Site status is shown where the registry gives one.
St. Joseph's Hospital and Medical Center-Norton Thoracic Institute
Phoenix, Arizona
University of Arizona
Tucson, Arizona
UCSD Health Sciences
La Jolla, California
Ronald Reagan UCLA Medical Center
Los Angeles, California
Keck Hospital of USC
Los Angeles, California
VA Greater Los Angeles Healthcare System
Los Angeles, California
University of California, Irvine
Orange, California
University of California Davis Medical Center
Sacramento, California
Santa Barbara Cottage Hospital
Santa Barbara, California
Stanford University Medical Center
Stanford, California
University of Colorado Hospital
Aurora, Colorado
National Jewish Health
Denver, Colorado
University of Florida
Gainesville, Florida
Central Florida Pulmonary Group
Orlando, Florida
Cleveland Clinic Florida
Weston, Florida
Emory University Hospital
Atlanta, Georgia
Piedmont Healthcare Pulmonary and Critical Care Research
Austell, Georgia
University of Chicago Medical Center
Chicago, Illinois
Ascension Alexian Brothers
Elk Grove Village, Illinois
Community Heart and Vascular Hospital
Indianapolis, Indiana
St. Vincent Medical Group, Inc.
Indianapolis, Indiana
University of Iowa Hospitals and Clinics
Iowa City, Iowa
University of Maryland Medical Center
Baltimore, Maryland
Tufts Medical Center
Boston, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Boston University Medical Center
Boston, Massachusetts
Spectrum Health Medical Group
Grand Rapids, Michigan
Washington University School of Medicine
St Louis, Missouri
University of New Mexico
Albuquerque, New Mexico
NYU Langone Medical Center
New York, New York
University of Rochester
Rochester, New York
Duke University Medical Center
Durham, North Carolina
East Carolina University
Greenville, North Carolina
University of Cincinnati-Medical Science Building
Cincinnati, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
Integris Baptist Medical Center
Oklahoma City, Oklahoma
Oregon Health & Science University
Portland, Oregon
University of Pennsylvania
Philadelphia, Pennsylvania
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania
Showing 40 of 190 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.